Roosevelt Investment Group LLC Global Blood Therapeutics, Inc. Transaction History
Roosevelt Investment Group LLC
- $1.39 Billion
- Q3 2022
A detailed history of Roosevelt Investment Group LLC transactions in Global Blood Therapeutics, Inc. stock. As of the latest transaction made, Roosevelt Investment Group LLC holds 146,845 shares of GBT stock, worth $0. This represents 0.72% of its overall portfolio holdings.
Number of Shares
146,845
Previous 802,390
81.7%
Holding current value
$0
Previous $25.6 Million
60.99%
% of portfolio
0.72%
Previous 1.84%
Shares
4 transactions
Others Institutions Holding GBT
# of Institutions
8Shares Held
288KCall Options Held
0Put Options Held
0-
Jefferies Group LLC New York, NY46.3KShares$00.03% of portfolio
-
S. Muoio & Co. LLC New York, NY40.7KShares$03.66% of portfolio
-
Taylor Wealth Management Partners Boston, MA27.9KShares$00.51% of portfolio
-
Sarissa Consulting LLC Santa Monica, CA26KShares$01.83% of portfolio
-
Wipfli Financial Advisors Llc,145Shares$00.0% of portfolio
About Global Blood Therapeutics, Inc.
- Ticker GBT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 67,476,200
- Market Cap $4.62B
- Description
- Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...